Telix Pharmaceuticals Limited, headquartered in Melbourne, has international operations including in Europe and is listed on the Australian Securities Exchange.

The entities involved

• TELIX PHARMACEUTICALS LIMITED →

  Australian public company

  • Telix agreed to acquire ITM Isotope Technologies Munich and is developing drugs that compete with Novartis.Wed 01:43
• Melbourne →

  capital city of Victoria, Australia

  • Daily Mail reported on warnings issued by a preacher in Melbourne.Mon 10:36
  • A tour is scheduled to include shows in Sydney, Adelaide, Melbourne, Perth, and Brisbane.Mon 09:53
• Australian Securities Exchange →

  public company that operates Australia's primary securities exchange

  • The Australian Securities & Investments Commission implements enhanced disclosure obligations on market activities.Thu 20:17
  • Corporate Travel Management (CTM) voluntarily suspended its shares from the Australian Securities Exchange (ASX).Thu 08:16
• Europe →

  terrestrial continent located in north-western Eurasia

  • The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
  • The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49

Related events

• MS INTERNATIONAL plc operates through various divisions across Europe and South America.Sep 20
• Air Astana Group operates in multiple global markets, including Europe, Central Asia, and India, and is listed on international exchanges.Jun 7
• Lanxess, a company headquartered in Cologne, maintains a global footprint across Europe and the Americas.Jun 12
• Babcock International Group operates in markets across North America, Europe, Africa, and Australasia.Aug 19
• Bio-Techne operates in European, US, and Middle Eastern markets and is listed on NASDAQ.Tue 20:20